Thank you.
I'd like to address a question to the BIOTECanada representatives. You've drawn a picture of what it is to be a small start-up biotech company: the fact that it takes a certain number of years to develop your promising idea into a product, the fact that currently many of the companies have only six months' or a year's worth of cash on hand. I think that very graphically describes the situation.
When that cash doesn't come and things have to stop, what most often happens to those companies? Do they just disappear? Do they get merged? Do they get acquired by bigger companies? What happens?